[HTML][HTML] CHST11 gene expression and DNA methylation in breast cancer
D Herman, TI Leakey, A Behrens… - International …, 2015 - spandidos-publications.com
Our previously published data link P-selectin-reactive chondroitin sulfate structures on the
surface of breast cancer cells to metastatic behavior of cells. We have shown that a …
surface of breast cancer cells to metastatic behavior of cells. We have shown that a …
Carbohydrate (chondroitin 4) sulfotransferase-11-mediated induction of epithelial-mesenchymal transition and generation of cancer stem cells
A Behrens, F Jousheghany, A Yao-Borengasser… - Pharmacology, 2020 - karger.com
Introduction: We have previously shown that the expression of carbohydrate (chondroitin 4)
sulfotransferase-11 (CHST11) is elevated in human breast cancer tissues, and that its …
sulfotransferase-11 (CHST11) is elevated in human breast cancer tissues, and that its …
Methylation-dependent silencing of CST6 in primary human breast tumors and metastatic lesions
AG Rivenbark, CA Livasy, CE Boyd, D Keppler… - … and molecular pathology, 2007 - Elsevier
CST6 is a breast tumor suppressor gene that is expressed in normal breast epithelium, but is
epigenetically silenced as a consequence of promoter hypermethylation in metastatic breast …
epigenetically silenced as a consequence of promoter hypermethylation in metastatic breast …
Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11gene expression in forming surface P-selectin ligands in …
CA Cooney, F Jousheghany, A Yao-Borengasser… - Breast cancer …, 2011 - Springer
Introduction We have previously demonstrated that chondroitin sulfate glycosaminoglycans
(CS-GAGs) on breast cancer cells function as P-selectin ligands. This study was performed …
(CS-GAGs) on breast cancer cells function as P-selectin ligands. This study was performed …
HS3ST2 modulates breast cancer cell invasiveness via MAP kinase‐ and Tcf4 (Tcf7l2)‐dependent regulation of protease and cadherin expression
A Vijaya Kumar, E Salem Gassar… - … journal of cancer, 2014 - Wiley Online Library
Heparan sulfate 3‐O‐sulfotransferase 2 (HS3ST2), an enzyme mediating 3‐O‐sulfation of
heparan sulfate (HS), is silenced by hypermethylation in breast cancer. As HS has an …
heparan sulfate (HS), is silenced by hypermethylation in breast cancer. As HS has an …
Prognostic impact of chondroitin-4-sulfotransferase CHST11 in ovarian cancer
L Oliveira-Ferrer, A Heßling, F Trillsch, S Mahner… - Tumor Biology, 2015 - Springer
Ovarian cancer (OvCa) accounts for the highest tumor-related mortality among
gynecological malignancies, but the underlying mechanisms are poorly understood …
gynecological malignancies, but the underlying mechanisms are poorly understood …
[HTML][HTML] DNA methylation-dependent silencing of CST6 in human breast cancer cell lines
AG Rivenbark, WD Jones, WB Coleman - Laboratory Investigation, 2006 - Elsevier
Cystatin M (CST6) is a candidate breast cancer tumor suppressor that is expressed in
normal and premalignant breast epithelium, but not in metastatic breast cancer cell lines …
normal and premalignant breast epithelium, but not in metastatic breast cancer cell lines …
CST6 promoter methylation in circulating cell-free DNA of breast cancer patients
M Chimonidou, A Tzitzira, A Strati, G Sotiropoulou… - Clinical …, 2013 - Elsevier
OBJECTIVES: We have recently shown that detection of CST6 promoter methylation in
primary breast tumors can provide important prognostic information in patients with operable …
primary breast tumors can provide important prognostic information in patients with operable …
[HTML][HTML] CHPF promotes malignancy of breast cancer cells by modifying syndecan-4 and the tumor microenvironment
Breast cancer is the leading cause of cancer-related deaths in women worldwide. Several
studies have indicated that abnormal chondroitin sulfate (CS) chains accumulate in breast …
studies have indicated that abnormal chondroitin sulfate (CS) chains accumulate in breast …
Methylation of cystatin M promoter is associated with unfavorable prognosis in operable breast cancer
M Kioulafa, I Balkouranidou… - … journal of cancer, 2009 - Wiley Online Library
The methylation status of cystatin M (CST6) gene in breast tumors was investigated and its
prognostic significance as a novel breast cancer biomarker was evaluated. Using …
prognostic significance as a novel breast cancer biomarker was evaluated. Using …